AVITA Medical, Inc. (RCEL)

8,26 -0,45 (-5,17%) Börsenschluss: 04:00PM EDT

AVITA Medical, Inc.

28159 Avenue Stanford
Suite 220
Valencia, CA 91355
United States
661 367 9170
https://www.avitamedical.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 207

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. James M. Corbett	CEO, President & Executive Director	1,16M	N/A	1958
Mr. David O'Toole	Chief Financial Officer	574,64k	N/A	1959
Ms. Donna Shiroma	General Counsel, Chief Compliance Officer & Secretary	688,6k	N/A	1963
Mr. David Fencil	Senior Vice President of Global Operations	N/A	N/A	N/A
Dr. Katie Bush Ph.D.	Senior Vice President of Scientific & Medical Affairs	N/A	N/A	N/A
Ms. Jessica Ekeberg	Investor Relations Executive	N/A	N/A	N/A
Ms. Debbie Garner	Senior Vice President of Global Marketing & Strategy	N/A	N/A	N/A
Mr. Rob Hall	Senior Vice President of Human Resources	N/A	N/A	N/A
Mr. Terry Bromley	Senior Vice President of Global Sales	N/A	N/A	N/A
Dr. Niraj Doshi J.D., P.M.P., Ph.D.	Senior Vice President of Product Development & Program Management	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

Corporate Governance

AVITA Medical, Inc.s ISS Governance QualityScore, Stand 1. Mai 2024, lautet 6. Die grundlegenden Scores sind Audit: 8, Vorstand: 3, Shareholderrechte: 5, Kompensation: 9.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.